Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Bronchiectasis | 13 | 2019 | 312 | 4.63 | Why? |
| Ciliary Motility Disorders | 2 | 2019 | 58 | 0.90 | Why? |
| Tiotropium Bromide | 2 | 2017 | 46 | 0.86 | Why? |
| Proteobacteria | 1 | 2018 | 36 | 0.76 | Why? |
| Scopolamine Derivatives | 1 | 2017 | 10 | 0.73 | Why? |
| Asthma | 5 | 2021 | 4383 | 0.57 | Why? |
| Rhinitis | 2 | 2019 | 626 | 0.55 | Why? |
| Macrolides | 1 | 2018 | 369 | 0.55 | Why? |
| Sinusitis | 2 | 2019 | 649 | 0.54 | Why? |
| Industry | 1 | 2017 | 347 | 0.53 | Why? |
| Rhinitis, Allergic | 5 | 2019 | 704 | 0.48 | Why? |
| Pulmonary Disease, Chronic Obstructive | 5 | 2022 | 3832 | 0.48 | Why? |
| Spirometry | 5 | 2018 | 524 | 0.45 | Why? |
| Sputum | 3 | 2018 | 1720 | 0.44 | Why? |
| Pulmonary Medicine | 1 | 2018 | 706 | 0.43 | Why? |
| Walking | 1 | 2015 | 442 | 0.42 | Why? |
| Cellulose | 3 | 2019 | 106 | 0.41 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.38 | Why? |
| Quality of Life | 6 | 2018 | 9820 | 0.37 | Why? |
| Exercise Test | 1 | 2015 | 911 | 0.36 | Why? |
| Cilia | 2 | 2019 | 183 | 0.36 | Why? |
| Cost of Illness | 1 | 2019 | 1903 | 0.35 | Why? |
| Nasal Mucosa | 3 | 2019 | 1218 | 0.32 | Why? |
| China | 17 | 2021 | 50654 | 0.31 | Why? |
| Research | 1 | 2017 | 2115 | 0.26 | Why? |
| Pharmaceutical Preparations | 1 | 2018 | 1897 | 0.25 | Why? |
| Pseudomonas aeruginosa | 2 | 2018 | 652 | 0.25 | Why? |
| Bronchodilator Agents | 2 | 2017 | 444 | 0.23 | Why? |
| Tomography, Optical Coherence | 2 | 2019 | 1008 | 0.22 | Why? |
| Hematologic Agents | 1 | 2021 | 57 | 0.21 | Why? |
| Health Behavior | 1 | 2018 | 4449 | 0.21 | Why? |
| Forced Expiratory Volume | 3 | 2017 | 632 | 0.21 | Why? |
| Tissue Array Analysis | 1 | 2019 | 75 | 0.20 | Why? |
| Antigens, Dermatophagoides | 1 | 2019 | 25 | 0.20 | Why? |
| Anti-Bacterial Agents | 3 | 2021 | 10083 | 0.20 | Why? |
| Pyroglyphidae | 1 | 2019 | 52 | 0.20 | Why? |
| Rhinitis, Allergic, Perennial | 1 | 2019 | 36 | 0.19 | Why? |
| Bronchioles | 1 | 2018 | 33 | 0.19 | Why? |
| Sickness Impact Profile | 1 | 2018 | 56 | 0.19 | Why? |
| Granulocyte Colony-Stimulating Factor | 1 | 2021 | 264 | 0.19 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.19 | Why? |
| Oscillometry | 1 | 2018 | 50 | 0.19 | Why? |
| Airway Remodeling | 1 | 2019 | 111 | 0.19 | Why? |
| Intracellular Space | 1 | 2018 | 60 | 0.18 | Why? |
| Air Pollution | 1 | 2017 | 3504 | 0.18 | Why? |
| Residual Volume | 1 | 2017 | 45 | 0.18 | Why? |
| Mucociliary Clearance | 1 | 2018 | 72 | 0.18 | Why? |
| Smog | 1 | 2017 | 8 | 0.18 | Why? |
| Chlorides | 1 | 2018 | 82 | 0.17 | Why? |
| Rhinitis, Allergic, Seasonal | 1 | 2019 | 121 | 0.17 | Why? |
| Renewable Energy | 1 | 2017 | 55 | 0.17 | Why? |
| Administration, Inhalation | 3 | 2019 | 1647 | 0.17 | Why? |
| Forkhead Transcription Factors | 1 | 2018 | 231 | 0.16 | Why? |
| Nasal Polyps | 1 | 2019 | 221 | 0.16 | Why? |
| Professional Practice Gaps | 1 | 2016 | 41 | 0.16 | Why? |
| Respiratory Function Tests | 3 | 2019 | 1755 | 0.16 | Why? |
| Airway Obstruction | 1 | 2018 | 182 | 0.15 | Why? |
| Humans | 40 | 2022 | 930598 | 0.15 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.14 | Why? |
| Virus Diseases | 3 | 2018 | 3779 | 0.14 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.14 | Why? |
| Health Services Accessibility | 1 | 2018 | 10697 | 0.14 | Why? |
| Culture | 1 | 2018 | 370 | 0.14 | Why? |
| Diagnostic Self Evaluation | 1 | 2018 | 394 | 0.14 | Why? |
| Adult | 20 | 2021 | 244371 | 0.13 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.13 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.13 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.12 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.12 | Why? |
| Bronchi | 1 | 2019 | 1048 | 0.12 | Why? |
| Male | 23 | 2021 | 367725 | 0.12 | Why? |
| Lung | 3 | 2020 | 31049 | 0.12 | Why? |
| RNA | 1 | 2019 | 1278 | 0.11 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.11 | Why? |
| Metagenomics | 1 | 2017 | 823 | 0.11 | Why? |
| Female | 22 | 2021 | 380317 | 0.10 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.10 | Why? |
| Psychometrics | 1 | 2017 | 1269 | 0.10 | Why? |
| Atherosclerosis | 1 | 2017 | 768 | 0.10 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.10 | Why? |
| Chronic Disease | 3 | 2019 | 5139 | 0.10 | Why? |
| Respiratory Mucosa | 1 | 2018 | 1522 | 0.09 | Why? |
| Cough | 3 | 2020 | 4891 | 0.09 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Physician-Patient Relations | 1 | 2018 | 1266 | 0.09 | Why? |
| Wounds and Injuries | 1 | 2021 | 1708 | 0.09 | Why? |
| Suicide | 1 | 2021 | 1500 | 0.09 | Why? |
| Outpatients | 2 | 2017 | 3417 | 0.08 | Why? |
| Disease Progression | 4 | 2021 | 13580 | 0.08 | Why? |
| Transcriptome | 1 | 2019 | 3466 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.08 | Why? |
| Fever | 2 | 2020 | 7795 | 0.08 | Why? |
| Attitude to Health | 1 | 2018 | 2002 | 0.07 | Why? |
| Respiratory System | 1 | 2018 | 3213 | 0.07 | Why? |
| Anxiety Disorders | 1 | 2017 | 2290 | 0.07 | Why? |
| Drugs, Chinese Herbal | 1 | 2020 | 2760 | 0.07 | Why? |
| Risk Factors | 4 | 2022 | 71621 | 0.07 | Why? |
| Viruses | 1 | 2017 | 2238 | 0.07 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.06 | Why? |
| Germany | 1 | 2019 | 9196 | 0.06 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.06 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.06 | Why? |
| Evidence-Based Medicine | 1 | 2016 | 3228 | 0.06 | Why? |
| Aging | 1 | 2019 | 3581 | 0.06 | Why? |
| Chiroptera | 1 | 2017 | 3530 | 0.06 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.06 | Why? |
| Aged | 10 | 2020 | 215776 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Capsules | 1 | 2020 | 140 | 0.05 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.05 | Why? |
| Powders | 1 | 2018 | 121 | 0.05 | Why? |
| Immediate-Early Proteins | 1 | 2018 | 44 | 0.05 | Why? |
| Airway Resistance | 1 | 2018 | 83 | 0.05 | Why? |
| Mice, Inbred Strains | 1 | 2018 | 136 | 0.04 | Why? |
| Respirovirus | 1 | 2018 | 122 | 0.04 | Why? |
| Simplexvirus | 1 | 2018 | 124 | 0.04 | Why? |
| Human bocavirus | 1 | 2018 | 142 | 0.04 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.04 | Why? |
| Brachial Artery | 1 | 2017 | 107 | 0.04 | Why? |
| Cross-Sectional Studies | 4 | 2019 | 53120 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Double-Blind Method | 2 | 2019 | 5988 | 0.04 | Why? |
| Carotid Intima-Media Thickness | 1 | 2017 | 179 | 0.04 | Why? |
| Americas | 1 | 2018 | 418 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| ROC Curve | 2 | 2019 | 6024 | 0.04 | Why? |
| Olfactory Mucosa | 1 | 2019 | 372 | 0.04 | Why? |
| Epithelial Cells | 2 | 2019 | 3508 | 0.04 | Why? |
| Geography, Medical | 1 | 2019 | 537 | 0.04 | Why? |
| Reference Values | 1 | 2019 | 795 | 0.04 | Why? |
| Pharyngitis | 1 | 2020 | 687 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2021 | 1517 | 0.04 | Why? |
| Vasodilation | 1 | 2017 | 258 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Metapneumovirus | 1 | 2018 | 465 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2019 | 1132 | 0.03 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2021 | 1562 | 0.03 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.03 | Why? |
| Geography | 1 | 2020 | 1801 | 0.03 | Why? |
| Child | 2 | 2020 | 70012 | 0.03 | Why? |
| Lipopolysaccharides | 1 | 2018 | 848 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| Severity of Illness Index | 5 | 2020 | 48226 | 0.03 | Why? |
| Depression | 1 | 2017 | 14116 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Environment | 1 | 2019 | 769 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.03 | Why? |
| Nose | 1 | 2019 | 1093 | 0.03 | Why? |
| Adrenal Cortex Hormones | 2 | 2021 | 6537 | 0.03 | Why? |
| Cytomegalovirus | 1 | 2018 | 600 | 0.03 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| Language | 1 | 2017 | 655 | 0.03 | Why? |
| Rhinovirus | 1 | 2018 | 979 | 0.03 | Why? |
| Adenoviridae | 1 | 2018 | 1151 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2016 | 15421 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2019 | 11304 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Prevalence | 3 | 2019 | 25773 | 0.03 | Why? |
| Chemokine CXCL10 | 1 | 2015 | 565 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Shock, Septic | 1 | 2021 | 1313 | 0.03 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.03 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2018 | 846 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.03 | Why? |
| Asia | 1 | 2018 | 2399 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2021 | 3786 | 0.03 | Why? |
| Biopsy | 1 | 2019 | 2811 | 0.03 | Why? |
| Immunization | 1 | 2019 | 2019 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Africa | 1 | 2018 | 2986 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2022 | 3607 | 0.02 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Endothelium, Vascular | 1 | 2017 | 1751 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2019 | 3129 | 0.02 | Why? |
| Animals | 3 | 2019 | 78931 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.02 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.02 | Why? |
| Zoonoses | 1 | 2017 | 3034 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Acute Disease | 1 | 2016 | 6029 | 0.02 | Why? |
| Cell Line | 1 | 2018 | 12040 | 0.01 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.01 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2015 | 9537 | 0.01 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Genome, Viral | 1 | 2017 | 13157 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Biomarkers | 1 | 2015 | 23361 | 0.01 | Why? |
| Coronavirus | 1 | 2018 | 18339 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.01 | Why? |